Back to Beacon Pointe Advisors, LLC Beacon Pointe Advisors, LLC

AVXLAVXL

Showing 8 of 23 quarters

Position history for Beacon Pointe Advisors, LLCBeacon Pointe Advisors, LLC's holdings in ANAVEX LIFE SCIENCES CORP

Yes. Beacon Pointe Advisors holds 23,185 shares of AVXL (Anavex Life Sciences), worth $60,050, as of its Q2 2026 13F filing. It increased the position by 185 shares (+0.8%) from Q1 2026. Beacon Pointe Advisors has held AVXL since Q4 2020, across 23 quarterly 13F filings.

Current Value

$60,050

Current Shares

23,185

Total Value Change

-$70,590

Total Shares Change

+185

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
23,185
+0.8%
$60,0500.0%$2.59
21
2026-Q1
Unchanged
23,000
0.0%
$70,6100.0%$3.07
0
2025-Q4
Unchanged
23,000
0.0%
$81,8800.0%$3.56
0
2025-Q3
Unchanged
23,000
0.0%
$204,7000.0%$8.90
0
2025-Q2
Unchanged
23,000
0.0%
$212,0600.0%$9.22
0
2025-Q1
Unchanged
23,000
0.0%
$197,3400.0%$8.58
0
2024-Q4
Unchanged
23,000
0.0%
$247,0200.0%$10.74
0
2024-Q3
Unchanged
23,000
0.0%
$130,6400.0%$5.68
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used